Northwestern University
Chicago, Illinois, 60611, United States
Location status: Recruiting
NCT Number: NCT07669753
The purpose of this study is to evaluate patient navigation programs designed to reduce barriers to cancer screening and improve healthcare experiences for adults living in Chicago. Participants will be asked to complete two surveys: the first survey shortly after the participants join the study and a second survey after 1 year. Participants will be joining one of three patient navigation programs, assigned at random. The investigators expect the participants to be in this patient navigation program for 12 months, followed by a 1-month window to complete the final survey.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Location status: Recruiting
This study focuses on improving how patient navigators (PNs) help people get cancer care in Chicago. The goal is to reduce differences in cancer outcomes between communities by tackling common challenges like language barriers, difficulty understanding health information, and trouble accessing care.
The program is based on priorities identified by community partners, including:
At the individual patient level, navigators will help people overcome obstacles (like scheduling, transportation, or understanding instructions). This support is expected to help patients complete important steps in their care, such as:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The standard health navigation group will work with a Health Navigator during the 12 months time in the study. A Health Navigator is a trained, non-clinical staff member who helps the participants understand and access cancer screening and follow-up care. They are not doctors or nurses, but they work to support the participants in navigating the healthcare system.
The standard Health Navigation with the "Get Healthy" checklist group will work with a Health Navigator and a guided checklist over the next 12 months.
A Health Navigator is a trained, non-clinical staff member who helps you understand and access cancer screening and follow-up care. They are not doctors or nurses, but they work to support you in navigating the healthcare system.
The health navigation with the AI chatbot group will work with a Health Navigator and an AI Chatbot over 12 months. A Health Navigator is a trained, non-clinical staff member who helps you understand and access cancer screening and follow-up care. They are not doctors or nurses, but they work to support you in navigating the healthcare system.
Time frame: From enrollment to the end of intervention at 12 months.
Patient Receipt of Clinical Cancer Preventive Services composite proportion of items completed/resolved in NCCN and USPSTF recommended cancer screenings, behavioral counseling, and immunizations.
Time frame: From enrollment to the end of intervention at 12 months.
Patient Receipt of Resolution of Social Determinants of Health (SDoH) Barriers is an adjusted, composite proportion of items completed/resolved from those identified in the Accountable Health Communities Health-Related Social Needs (AHC HRSN) Screening Tool.
Contact information is provided by the study sponsor or research team.
Ivy Leung
CONTACT
Melissa Simon
CONTACT
Northwestern University
Other
Advancing Cancer Control Engaged Research Through Transformative Solutions in Patient Navigation (ACCERT PN) Center
Acronym: ACCERT SDoH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05754801
Cancer, Neoplasms
Hong Kong
View Trial DetailsNCT05885048
Cancer, Effects of Immunotherapy
Bern, Switzerland
View Trial DetailsNCT05350761
Cancer, Environment
Bethesda, Maryland, United States
View Trial DetailsNCT07729969
Cancer, Cognition Disorders
Bilbao, Bizkaia, Spain
View Trial Details